58
Participants
Start Date
February 1, 2016
Primary Completion Date
March 31, 2019
Study Completion Date
March 31, 2019
ICS dose reduction
"If control of symptoms is maintained (evaluation based on clinical symptoms solely), every 3 months the dose of ICS is halved according to GINA guidelines, until the control is lost or the lowest daily dose is reached (200 mcg, calculated as budesonide equivalent).~In the case of loss of asthma control, beta-mimetic will be administered (temporarily) and return to the chronic administration of the previous, twice higher dose of ICS is restored (or further increase of treatment). In severe exacerbations, inclusion of oral steroids will be considered."
The Regional Public Hospital in Lesko, Poland, Lesko
University of Rzeszow
OTHER
The Regional Public Hospital in Lesko, Poland
OTHER
National Institute for Tuberculosis and Lung Diseases, Poland
OTHER